Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Warren Alpert Medical School of Brown University | - |
Autor(es): dc.contributor | Inc. | - |
Autor(es): dc.contributor | Hospital Universitario Ramón y Cajal | - |
Autor(es): dc.contributor | Universidade Estadual Paulista (Unesp) | - |
Autor(es): dc.contributor | Brown University | - |
Autor(es): dc.creator | Wambier, Carlos Gustavo | - |
Autor(es): dc.creator | Goren, Andy | - |
Autor(es): dc.creator | Vaño-Galván, Sergio | - |
Autor(es): dc.creator | Ramos, Paulo Müller [UNESP] | - |
Autor(es): dc.creator | Ossimetha, Angelina | - |
Autor(es): dc.creator | Nau, Gerard | - |
Autor(es): dc.creator | Herrera, Sabina | - |
Autor(es): dc.creator | McCoy, John | - |
Data de aceite: dc.date.accessioned | 2022-02-22T00:30:31Z | - |
Data de disponibilização: dc.date.available | 2022-02-22T00:30:31Z | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2019-12-31 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.1002/ddr.21688 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/200405 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/200405 | - |
Descrição: dc.description | In this communication, we present arguments for androgen sensitivity as a likely determinant of COVID-19 disease severity. The androgen sensitivity model explains why males are more likely to develop severe symptoms while children are ostensibly resistant to infection. Further, the model explains the difference in COVID-19 mortality rates among different ethnicities. Androgen sensitivity is determined by genetic variants of the androgen receptor. The androgen receptor regulates transcription of the transmembrane protease, serine 2 (TMPRSS2), which is required for SARS-CoV-2 infectivity. TMPRSS2 primes the Spike protein of the virus, which has two consequences: diminishing viral recognition by neutralizing antibodies and activating SARS-CoV-2 for virus-cell fusion. Genetic variants that have been associated with androgenetic alopecia, prostate cancer, benign prostatic hyperplasia and polycystic ovary syndrome could be associated with host susceptibility. In addition to theoretical epidemiological and molecular mechanisms, there are reports of high rates of androgenetic alopecia of from hospitalized COVID-19 patients due to severe symptoms. Androgen sensitivity is a likely determinant of COVID-19 disease severity. We believe that the evidence presented in this communication warrants the initiation of trials using anti-androgen agents. | - |
Descrição: dc.description | Department of Dermatology Warren Alpert Medical School of Brown University | - |
Descrição: dc.description | Applied Biology Inc. | - |
Descrição: dc.description | Trichology Unit Hospital Universitario Ramón y Cajal | - |
Descrição: dc.description | Department of Dermatology and Radiotherapy São Paulo State University – UNESP | - |
Descrição: dc.description | Brown University | - |
Descrição: dc.description | Division of Infectious Diseases Department of Medicine Warren Alpert Medical School of Brown University | - |
Descrição: dc.description | Department of Dermatology and Radiotherapy São Paulo State University – UNESP | - |
Idioma: dc.language | en | - |
Relação: dc.relation | Drug Development Research | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | alopecia | - |
Palavras-chave: dc.subject | androgens | - |
Palavras-chave: dc.subject | anti-androgen | - |
Palavras-chave: dc.subject | clinical trial | - |
Palavras-chave: dc.subject | COVID-19 | - |
Palavras-chave: dc.subject | pandemic | - |
Palavras-chave: dc.subject | SARS-CoV-2 | - |
Palavras-chave: dc.subject | TMPRSS2 | - |
Título: dc.title | Androgen sensitivity gateway to COVID-19 disease severity | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: